000 01562 a2200409 4500
005 20250518041700.0
264 0 _c20200910
008 202009s 0 0 eng d
022 _a1029-2403
024 7 _a10.1080/10428194.2019.1613537
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKloos, Robin Q H
245 0 0 _aThe effect of asparaginase therapy on methotrexate toxicity and efficacy in children with acute lymphoblastic leukemia.
_h[electronic resource]
260 _bLeukemia & lymphoma
_c12 2019
300 _a3002-3010 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAge Factors
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadverse effects
650 0 4 _aAsparaginase
_xadministration & dosage
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aDrug-Related Side Effects and Adverse Reactions
_xdiagnosis
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMethotrexate
_xadministration & dosage
650 0 4 _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma
_xdiagnosis
650 0 4 _aTreatment Outcome
700 1 _aPieters, Rob
700 1 _avan den Bos, Cor
700 1 _avan Eijkelenburg, Natasha K A
700 1 _ade Jonge, Robert
700 1 _avan der Sluis, Inge M
773 0 _tLeukemia & lymphoma
_gvol. 60
_gno. 12
_gp. 3002-3010
856 4 0 _uhttps://doi.org/10.1080/10428194.2019.1613537
_zAvailable from publisher's website
999 _c29721258
_d29721258